Aurinia Pharmaceuticals Inc. Financials

Market Capitalization C$2.15 Billion as of July 1, 2021

Valuations Metrics as of Jan. 25, 2025

Trailing PE	0.00
Forward PE	-128.92
Price to Sales TTM	C$42.11
Price to Book MRQ	C$5.80
Enterprise to Revenue	36.49
Enterprise to EBITDA	-14.77

Financial Reports as of Jun. 30, 2021

Financials

Fiscal Year Ends	2020-12-31
Most Recent Quarter	2021-06-30
Profit Margin	-249.26%
Operating Margin	-250.53%
Return on Assets TTM	-21.82%
Return on Equity TTM	-40.13%

Income Statement

Revenue TTM	C$51,002,000
Revenue per Share TTM	C$0.42
Quarterly Revenue Growth	2946.70%
Gross Profit TTM	C$-209,000
EBITDA	C$-126,012,000
Net Income to Common TTM	C$-127,127,000
Diluted EPS TTM	C$-1.28
Quarterly Earnings Growth YoY	22727.59%

Balance Sheet

Total Cash MRQ	C$348,259,008
Total Cash per Share MRQ	C$2.72
Total Debt MRQ	C$
Total Debt to Equity MRQ	2.40
Current Ratio MRQ	17.60
Book Value per Share MRQ	C$2.89

Cash Flow

Operating Cash Flow TTM	C$-100,791,000
Levered Free Cash Flow TTM	C$-71,047,128

AUP Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	128,156,000
Float Shares	122,926,363
Avg 10 Volume	4,611,685
Avg 30 Volume	None
Shares Short	993,772
Short Ratio	4.97
Short % of Shares	0.78%
% Held by Insiders	8.02%
% Held by Institutions	46.85%

Stock Price Summary

Beta	0.36
Fifty Two Week Low	C$11.77
Fifty Two Week High	C$26.00
Fifty Two Week Change	0.00%
Day 50 MA	C$15.69
Day 200 MA	C$16.69

Dividends and Splits

Forward Annual Dividend Rate	C$0.00
Forward Annual Dividend Yield	0.00%
Trailing Annual Dividend Rate	C$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date	1970-01-01
Ex Dividend Date	1970-01-01
Last Split Factor
Last Split Date